Terug
Dagbereik
€ 23,57
€ 25,33
52-Weeksbereik
€ 4,66
€ 32,63
Volume
287.694
50D / 200D Gem.
€ 26,59
/
€ 19,96
Vorige Slotkoers
€ 24,18
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -21,9 | 0,4 |
| P/B | 2,8 | 2,9 |
| ROE % | -12,2 | 3,7 |
| Net Margin % | -106,4 | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 39,00
+64.0%
Low: € 28,00
High: € 60,00
Forward WPA
-€ 1,64
Omzet Sch.
68 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 3,61
-€ 5,23 – -€ 2,04
|
84 M | 2 |
| FY2029 |
-€ 3,52
-€ 5,09 – -€ 1,99
|
50 M | 2 |
| FY2028 |
-€ 2,73
-€ 3,63 – -€ 1,76
|
64 M | 4 |
Belangrijkste Punten
Debt/Equity of 0,06 — conservative balance sheet
Generating 109,67M in free cash flow
PEG of 0,30 suggests growth is underpriced
Capital efficient — spends only 1,13% of revenue on capex
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)4174,51%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-12,19%
ROIC-14,94%
Net Margin-106,37%
Op. Margin-175,83%
Veiligheid
Debt / Equity
0,06
Current Ratio4,73
Interest Coverage0,00
Waardering
P/E Ratio
-21,85
P/B Ratio2,80
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4174,51% | Revenue Growth (3Y) | 1644,45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 45,95M | Net Income (TTM) | -48,88M |
| ROE | -12,19% | ROA | -8,20% |
| Gross Margin | 96,51% | Operating Margin | -175,83% |
| Net Margin | -106,37% | Free Cash Flow (TTM) | 109,67M |
| ROIC | -14,94% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,06 | Current Ratio | 4,73 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -21,85 | P/B Ratio | 2,80 |
| P/S Ratio | 23,24 | PEG Ratio | 0,30 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,07B | Enterprise Value | 970,78M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 45,95M | 1,08M | 151.000,0 | 0,0 |
| Net Income | -48,88M | -71,80M | 4,18M | -27,68M |
| EPS (Diluted) | -1,10 | -7,26 | 0,03 | -1,42 |
| Gross Profit | 44,35M | 1,08M | 151.000,0 | 0,0 |
| Operating Income | -80,80M | -80,82M | 2,08M | -27,97M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 596,19M | 456,55M | 130,87M | 36,12M |
| Total Liabilities | 214,26M | 36,51M | 169,24M | 80,32M |
| Shareholders' Equity | 381,93M | 420,05M | -38,37M | -44,20M |
| Total Debt | 23,63M | 25,48M | 12,57M | 710.000,0 |
| Cash & Equivalents | 120,72M | 238,20M | 88,48M | 30,61M |
| Current Assets | 410,96M | 356,82M | 112,68M | 31,89M |
| Current Liabilities | 86,93M | 12,85M | 6,91M | 5,54M |